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As shown earlier, raft-like domains resembling those thought to be
present in natural cell membranes can be formed in supported
planar lipid monolayers. These liquid-ordered domains coexist
with a liquid-disordered phase and form in monolayers prepared
both from synthetic lipid mixtures and lipid extracts of the brush
border membrane of mouse kidney cells. The domains are deter-
gent-resistant and are highly enriched in the glycosphingolipid
GM1. In this work, the properties of these raft-like domains are
further explored and compared with properties thought to be
central to raft function in plasma membranes. First, it is shown that
domain formation and disruption critically depends on the choles-
terol density and can be controlled reversibly by treating the
monolayers with the cholesterol-sequestering reagent methyl-b-
cyclodextrin. Second, the glycosylphosphatidylinositol-anchored
cell-surface protein Thy-1 significantly partitions into the raft-like
domains. The extent of this partitioning is reduced when the
monolayers contain GM1, indicating that different molecules can
compete for domain occupation. Third, the partitioning of a satu-
rated phospholipid analog into the raft phase is dramatically
increased (15% to 65%) after cross-linking with antibodies,
whereas the distribution of a doubly unsaturated phospholipid
analog is not significantly affected by cross-linking ('10%). This
result demonstrates that cross-linking, a process known to be
important for certain cell-signaling processes, can selectively trans-
locate molecules to liquid-ordered domains.
membrane domains u receptor cross-linking u cholesterol u
glycosylphosphatidylinositol-anchored proteins u signal transduction
Treatment of cell lysates with cold nonionic detergent andsubsequent sucrose gradient centrifugation allows extraction
of a detergent-resistant membrane fraction (DRM) (1, 2). The
finding that this fraction is enriched in cholesterol and sphin-
golipids that form a liquid-ordered phase (3, 4) has led to the
hypothesis that the DRM arises directly from discrete liquid-
ordered domains in the plasma membrane termed lipid rafts (5,
6). Such domains could be important for membrane trafficking
and sorting (1, 7). Moreover, cell signaling molecules are en-
riched in the DRM, and the partitioning of these molecules into
the DRM is altered during signaling (8–12). Extraction of
cholesterol from plasma membranes affects the abundance of
molecules found in the DRM and impairs processes like mem-
brane trafficking (13, 14) and cell activation (15, 16). These
findings suggest that lipid rafts on plasma membranes are
maintained by proper cholesterol levels as functional, preas-
sembled signal transduction complexes (17–19).
Although there is accumulating evidence suggesting that some
form of lipid domains or clusters are present in cell membranes,
there is still considerable controversy surrounding the basic physical
properties of these domains (compositional diversity, size, struc-
ture, and dynamics) and their relation to the DRM (for review see
refs. 20 and 21). The raft hypothesis proposes that naturally
occurring lipids such as sphingomyelin (SM), cholesterol, glyco-
sphingolipids, and perhaps saturated phospholipids specifically
aggregate in the plane of the membrane, driven solely or primarily
by distinct lipid–lipid interactions (5, 22, 23). We have previously
demonstrated that detergent-resistant, liquid-ordered domains can
be directly imaged in the free-standing lipid lamella of giant
unilamellar vesicles and in planar-supported bilayers and mono-
layers, formed both from artificial lipid mixtures approximating the
plasma membrane lipid composition and natural lipid extracts from
the brush border membrane (BBM) of mouse kidney cells (24).
These results are consistent with other work showing that liquid-
disordered and liquid-ordered phases can coexist in model mem-
branes (25–27) and that the liquid-ordered phase is partially resis-
tant to detergent (28, 29). These studies lend strong support to the
notion that raft domains in cell membranes can arise primarily from
lipid–lipid interactions.
In the present work, f luorescence microscopy is used to
explore several key properties of raft-like domains reconstituted
in model systems consisting of Langmuir monolayers transferred
from the water-air interface to silanized glass supports. The
results are interpreted in terms of their relevance to the under-
lying physical factors governing how rafts in cell membranes
might mediate cell signaling events. Because cholesterol is
known to strongly influence the abundance and chemical com-
position of DRM isolated from cell membranes, the effects of
cholesterol extraction and repletion on raft-like domains in the
model system have been examined. Because glycosphingolipids
and glycosylphosphatidylinositol (GPI)-linked proteins are
thought to preferentially associate with rafts on plasma mem-
branes, the relative partitioning of the glycosphingolipid GM1
and the GPI-linked protein Thy-1 between the liquid-ordered
and liquid-disordered regions in supported monolayers has been
investigated. Finally, in that molecular cross-linking is a key step
in the initiation of certain signal transduction events and is
known to influence receptor occupation in the DRM of certain
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cell types, the partitioning of phospholipid analogs between the
two phases, in the model system, before and after cross-linking
with antibodies also has been examined.
Materials and Methods
Materials. 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC),
cholesterol, brain SM, ovine ganglioside GM1 (GM1), and
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-f luorescein
(FL-DOPE) were purchased from Avanti Polar Lipids. 1,2-
Dipalmitoyl-sn-glycero-3-phosphoethanolamine-f luorescein
(FL-DPPE), 1,2- dipalmitoyl-sn-glycero-3-phospho-ethanol-
amine-x-Texas red (TR-DPPE), and Alexa594-conjugated rabbit
polyclonal antif luorescein antibodies were obtained from Mo-
lecular Probes. Fluorescein-conjugated cholera toxin B subunit
(FL-CTB), the cholesterol-sequestering agent methyl-b-
cyclodextrin (MbCD), and water-soluble cholesterol (i.e.,
MbCD loaded with cholesterol) were obtained from Sigma.
Rhodamine-conjugated CTB was obtained by conjugating lissa-
mine rhodamine B sulfonyl chloride (Molecular Probes) to CTB
(Sigma). Lipids were extracted from BBMs, and the GPI-linked
protein Thy-1 was purified from a T cell lymphoma and labeled
with fluorescein isothiocyanate (F-Thy-1), as described in the
supporting information, which is published on the PNAS web
site, www.pnas.org. PBS was prepared from 50 mM sodium
phosphate, 150 mM NaCl, and 0.01% NaN3 (pH 7.4). A puri-
fication system provided water with a specific resistance of 17
MVzcm.
Preparation of Planar-Supported Lipid Monolayers. Supported lipid
monolayers were prepared by transfer from the water-air inter-
face of a Langmuir trough to silanized glass coverslips as
described (24). Host lipids were either lipid extracts from BBM
(see supporting information), DOPCySM (1:1, molymol), or
DOPCySMycholesterol (1:1:1, molymolymol). Fluorescent
lipid probes andyor GM1 were added to these solutions at
concentrations less than 1 mol%. Coverslip-supported monolay-
ers were mounted on glass slides with spacers to form chambers
containing '90 ml of PBS and kept at 24°C for all subsequent
preparation steps. To change the composition of the fluid
adjacent to supported monolayers, 100 ml of the desired solution
was gently injected while for flushing steps 300–400 ml of buffer
was applied.
F-Thy-1 was reconstituted into supported lipid monolayers by
first diluting 250–300 mgyml F-Thy-1 in a buffered solution of
40 mM n-octyl-b-D-glucopyranoside (see supporting informa-
tion) 10-fold with PBS. The final detergent concentration was 4
mM, well below the critical micelle concentration of 20 mM (30,
31). One hundred microliters of diluted F-Thy-1 was then
immediately injected into the fluid adjacent to a supported
monolayer. Samples were allowed to equilibrate for 2 h before
flushing the chamber with 400 ml PBS.
Fluorescence Microscopy. Fluorescence imaging, video fluores-
cence recovery after photobleaching (FRAP), and spot FRAP
measurements were carried out as described in supporting
information.
Cross-Linking Fluorescein-Conjugated Phospholipid Analogs.
Alexa594-conjugated antif luorescein antibodies were dissolved
in 200 ml PBS (15 mgyml) and clarified for 15 min at 11,400 g.
The top 100 ml of the supernatant was carefully removed and
injected into the volume adjacent to a supported lipid monolayer
containing 0.5 mol% FL-DOPE or FL-DPPE. After 15 min,
unbound antibody was removed by washing with 300 ml PBS.
Samples were allowed to equilibrate for an additional 45 min
before acquiring fluorescence micrographs. Treating monolay-
ers that did not contain FL-DPPE or FL-DOPE with Alexa594-
conjugated antif luorescein antibodies produced only a faint
signal in the red channel, which was without significance ('5%)
when compared with the fluorescence obtained for monolayers
containing fluorescein-conjugated lipids. In the latter case, the
fluorescence signal was significantly quenched in the green
channel, as expected after specific antibody binding (32, 33). The
reduction in intensity ('40%) was similar for both FL-DOPE
and FL-DPPE, suggesting that approximately equivalent densi-
ties of antibodies were bound for monolayers containing the two
fluorescent lipid analogs.
Relative Partitioning of Molecules into the Raft Phase. To quantify
the partitioning of fluorescent probe molecules between raft and
nonraft phases, the average intensities of areas corresponding to
these phase regions were calculated from 12-bit digitized charge-
coupled device fluorescence micrographs. The intensities were
corrected for dark counts and stray light by subtracting the
average background intensity measured for samples not con-
taining transferred lipid layers. The relative partition coefficient,
R, was defined as R 5 Iry(Ir 1 In) where Ir and In were the
background-corrected average intensities measured in the raft
and nonraft regions, respectively. Under ideal conditions, the
quantum efficiencies of the fluorophores attached to the probe
molecules and the lipid matrix densities are identical for both
lipid phases. In this case, the background-corrected fluorescence
intensities accurately reflect the relative concentrations of the
probe molecules in the two lipid phases.
Results
Cholesterol Critically Controls the Abundance of the Raft-Like Phase.
As described (24), planar-supported monolayers prepared from
synthetic raft-lipid mixtures (i.e., equimolar amounts of unsat-
urated phospholipids, cholesterol, and SM) or from lipid extracts
of BBMs contain coexisting fluid–fluid domains at room tem-
perature. Because liquid-ordered phases depend on the presence
of cholesterol, the response of supported lipid monolayers
containing coexisting liquid-ordered and liquid-disordered
phases to cholesterol depletion was examined. In what follows,
we refer to the liquid-ordered phases as raft-like domains
or phases. Fig. 1a shows a fluorescence image of a DOPCy
SMycholesterol monolayer with 1 mol% GM1 and 0.5 mol%
FL-DPPE after transfer at 35 dyneycm onto a silanized glass
coverslip. In these monolayers, FL-DPPE partitions into the
liquid-disordered phase (24). Microdomains are not present
within optical resolution after treatment with 10 mM MbCD
(Fig. 1b), a reagent that has been used in a number of studies to
extract cholesterol from phospholipid membranes (e.g., refs. 15,
34, and 35). The homogeneous distribution of FL-DPPE is not
visually changed after resupplementing cholesterol by subse-
quent treatment with 30 mgyml water-soluble cholesterol (Fig.
1c), but FL-DPPE mobility is significantly reduced by a factor of
'2, as measured by spot FRAP. After further treatment with 5
mM MbCD, monolayers again exhibit a heterogeneous FL-
DPPE distribution (Fig. 1d) very similar in appearance to that of
the original film state. To confirm that the nonfluorescent
regions that were produced in the monolayers after cholesterol
extraction, repletion, and final extraction (Fig. 1d) were not
lipid-depleted defects caused by the extended preparation steps,
monolayers were treated with rhodamine-conjugated CTB (RH-
CTB) to probe for the presence of GM1. As shown in Fig. 1e,
RH-CTB identifies the GM1-containing raft-like domains (Low-
er), which appear dark with respect to FL-DPPE fluorescence
(Upper). These results demonstrate that the presence of the
coexisting phases critically depends on the cholesterol density:
Repleting cholesterol took the monolayer into a uniform high-
cholesterol density phase and only after partial redepletion did
the raft phase reappear. Supported monolayers prepared with-
out cholesterol (DOPCySM) were in a homogeneous fluid







crystalline state as judged by video FRAP measurements (data
not shown).
Coexisting raft-like and liquid-disordered domains are present
not only in monolayers prepared from synthetic lipids but also in
monolayers prepared from BBM lipid extracts (Fig. 2a Left). The
raft-like domains exclude TR-DPPE (Fig. 2a Left) but are highly
enriched in GM1 when this glycosphingolipid is added to the
lipid extracts at 1 mol% and labeled with FL-CTB (24). Both
phases are liquid crystalline, as readily seen by conducting video
FRAP for TR-DPPE in regions containing both an enclosed
GM1-enriched domain and a smaller TR-DPPE-enriched inclu-
sion within this domain (Fig. 2b). TR-DPPE in the small
inclusion readily exchanges with TR-DPPE from the region
surrounding the GM1-enriched domain, indicating that TR-
DPPE mobility in the GM1-enriched raft-like domains is signif-
icant. Together with the observation that extraction of choles-
terol causes domain ‘‘melting’’ (Fig. 2a Center), we conclude that
the original domains are in a cholesterol-enriched liquid-ordered
phase state. Repletion of cholesterol leads to the formation of a
liquid-ordered phase (Fig. 2a Right) that covers most of the
monolayer and coexists with small domains enriched in TR-
DPPE, which are presumably in a liquid-disordered state. Con-
sistent with this interpretation, spot FRAP indicates that TR-
DPPE in the more abundant phase has a diffusion coefficient
that is '2-fold lower than the coefficient in the cholesterol-
depleted lipid monolayer (Fig. 2 Center and Right).
In contrast to the homogeneous monolayers composed of the
synthetic lipid mixture DOPCySM, domains that exclude TR-
DPPE form in monolayers prepared from cholesterol-depleted
BBM lipid extracts (more than 95% cholesterol removal) (Fig. 2c
Left). [The reason for the difference between Fig. 2 a and c is
most likely that to see the apparent gel phase in BBM mono-
layers, almost all of the cholesterol (.95%) must be removed.
With MbCD extraction, this condition cannot be met.] However,
Fig. 1. Effect of cholesterol (chol) on the raft-like phase in monolayers prepared from synthetic lipids. DOPCySMycholesterol monolayers were transferred
at 35 dyneycm onto silanized glass coverslips. The synthetic lipid mixture also contained 1 mol% GM1 and 0.5 mol% FL-DPPE. The distribution of FL-DPPE was
imaged after (a) exchange of the bulk solution from water to PBS and subsequent treatments for 15 min with PBS containing (b) 10 mM MbCD, (c) 30 mgyml
water-soluble cholesterol, and (d) 5 mM MbCD. GM1 was visualized (e Lower) by incubating the lipid layer for 5 min with rhodamine-conjugated CTB (2.5 mgyml)
and its distribution was compared with that of FL-DPPE (e Upper). The diffusion coefficients of FL-DPPE were measured by spot FRAP. The beam size is indicated
as E (Ø 2 mm). T 5 24°C. (Bars are 2 mm.)
Fig. 2. Effect of cholesterol (chol) on the raft-like phase in monolayers prepared from BBM lipid extracts. Monolayers composed of BBM lipids extracts with
0.4 mol% TR-DPPE and either (a) containing or (c) depleted of cholesterol (see Materials and Methods) were transferred at 32 dyneycm onto silanized glass
coverslips. Fluorescence micrographs show monolayers (Left) immediately after transfer onto supports; (Center) after being treated with 10 mM MbCD for 15
min; and (Right) after subsequent incubation with 30 mgyml water-soluble cholesterol for 15 min. Video FRAP measurements, carried out before MbCD
treatment, are depicted for monolayers prepared from (b) BBM and (d) cholesterol-depleted BBM lipid extracts. These images show TR-DPPE fluorescence before
bleaching in the areas indicated by the E and after allowing fluorescence recovery to occur. T 5 24°C. (All bars are 2.5 mm.)
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several lines of evidence indicate that these domains are in a
gel-phase state. First, video FRAP measurements (Fig. 2d)
indicate that the small inclusions enriched in TR-DPPE do not
recover after large-area bleaching, even after several hours.
Second, treatment with MbCD to reduce cholesterol levels does
not melt the domains, but instead leaves them essentially un-
changed (Fig. 2c Center). Third, the addition of water-soluble
cholesterol into the bulk phase melts the domains (Fig. 2c Right).
The GPI-Linked Protein Thy-1 Significantly Partitions into the Raft-Like
Phase. The DRM from a variety of cell types is enriched in
GPI-anchored proteins, suggesting that these proteins preferen-
tially associate with lipid rafts in cell membranes (36–39).
Therefore, a GPI-anchored protein (F-Thy-1) was reconstituted
into supported lipid monolayers by detergent dilution and its
distribution and dynamics were examined with fluorescence
microscopy. These reconstitution studies were carried out on
monolayers prepared both from BBM lipid extracts and
DOPCySMycholesterol. The lateral mobility of F-Thy-1 was
comparable to that of fluorescent phospholipid analogs (e.g.,
D 5 0.52 6 0.18 mm2ys measured by spot FRAP for
DOPCySMycholesterol raft mixture). In control measurements
with TR-DPPE-labeled supported monolayers, treatment for 2 h
with 4 mM n-octyl-b-D-glucopyranoside in PBS did not cause
measurable changes either in relative area coverage or relative
fluorescence intensities of coexisting lipid phases.
Fig. 3 shows a supported lipid monolayer prepared from BBM
lipid extracts without fluorescent lipids or GM1 added, into
which F-Thy-1 was incorporated. The image contrast, based on
the fluorescence intensities of F-Thy-1, indicates the presence of
two distinct lipid phases. As shown, video FRAP measurements
demonstrated that both phases are fluid and that exchange of
F-Thy-1 rapidly occurs between the two phases. In a set of
measurements with monolayers prepared from BBM lipid ex-
tracts or synthetic raft-lipid mixtures, the relative partitioning of
F-Thy-1 into the raft phase was examined, both in the absence
and presence of GM1 (1 mol%). To unambiguously identify the
coexisting phases, small amounts of TR-DPPE (0.2 mol%) were
incorporated. This lipid brightly stains the liquid-disordered
phase while being depleted from the raft-like phase (R '0.05 for
all lipid compositions used). Fig. 4 shows typical f luorescence
micrographs for BBM monolayers either not containing (Top) or
containing (Middle) GM1. Fluorescence intensities are shown
for TR-DPPE (Left, red channel) and F-Thy-1 (Right, green
channel). In preparations without GM1, raft-like domains ap-
pear bright in F-Thy-1 fluorescence, whereas the contrast is
inverted for preparations containing GM1. This result indicates
that the tendency of F-Thy-1 to partition into the liquid-ordered
phase (dark in TR-DPPE fluorescence image) is reduced in the
presence of 1 mol% GM1. As illustrated with the R values
measured for F-Thy-1 (Fig. 4), the same effect was observed for
monolayers prepared from synthetic raft-lipid mixtures
(DOPCySMycholesterol). For both natural and synthetic lipid
mixtures, the relative partitioning value of F-Thy-1 significantly
drops when GM1 is present, suggesting that the two molecules
compete for raft domain occupation.
Cross-Linking by mAbs Can Translocate Fluorescent Phospholipid
Analogs from the Liquid-Disordered to the Liquid-Ordered Phase.
Receptor cross-linking is a key step in the initiation of signal
transduction and can influence receptor occupation in the DRM
of certain cell types (39, 40). Therefore, the distributions of two
fluorescent phospholipid analogs (FL-DOPE and FL-DPPE)
Fig. 3. Distribution and dynamics of the GPI-linked protein Thy-1 in sup-
ported lipid monolayers. F-Thy-1 was reconstituted into a BBM lipid mono-
layer by detergent dilution. Fluorescence image panels (green channel) show
a video FRAP sequence. T 5 24°C.
Fig. 4. Effect of GM1 on F-Thy-1 partitioning between the liquid-disordered
and raft-like phases. Lipid monolayers, prepared either from BBM lipid ex-
tracts or synthetic lipid raft mixtures, were labeled with 0.1 mol% TR-DPPE,
and either did not contain or contained 1 mol% GM1. F-Thy-1 was incorpo-
rated into the monolayers by detergent dilution. Fluorescence micrographs
show BBM preparations without GM1 (Top) and with GM1 (Middle) imaged in
the red (Left, TR-DPPE) and green (Right, F-Thy-1) channels. The plot (Bottom)
shows the relative partition coefficient R, for F-Thy-1 into the liquid-ordered
phase, for both lipid compositions and in the absence and presence of GM1.
T 5 24°C. (Bar 5 10 mm.)







before and after cross-linking by an Alexa594-labeled antif luo-
rescein polyclonal antibody were examined. Fig. 5 shows two
typical sets of measurements, carried out for supported lipid
monolayers composed of synthetic raft-lipid mixtures containing
1 mol% GM1 and 0.5 mol% of either FL-DOPE (Upper) or
FL-DPPE (Lower). Both fluorescent lipids, in the monomeric
state before antibody treatment, exhibit only a small tendency to
partition into the raft-like phase, with R values of '0.07 for
FL-DOPE and '0.14 for FL-DPPE. In these images, the raft-
like domains appear dark (yellow panels). Cross-linked unsat-
urated phospholipids remained in the liquid-disordered phase
and the image contrast (red panel, Upper) and R values (plot)
were not significantly altered by antibody binding. Remarkably,
the image contrast was inverted for cross-linked FL-DPPE (R '
0.65, Fig. 5), and the originally dark raft-like domains (yellow
panel, Lower) appeared bright with Alexa594 imaging (red
panel, Lower). To clearly identify the raft-like phase, green-
channel images were recorded for antibody-treated monolayers
stained with FL-CTB (green panels). In these images, the
fluorescein-conjugated lipids contributed only moderately to the
fluorescence intensity ('10%), because of the high affinity of
FL-CTB for GM1 and the fact that the antif luorescein antibodies
significantly quench the fluorescein fluorescence upon binding
(see Materials and Methods). Longer antibody incubation times
(up to 6 h) or equilibration times (up to 24 h) did not alter the
results obtained for 15-min incubation and 45-min equilibration
times. This result suggests that the recorded micrographs reflect
an equilibrium or quasi-equilibrium distribution of the cross-
linked lipids. Cross-linked complexes remained mobile in both
phases as measured by video FRAP (not shown).
Discussion
Raft Domain Formation in Planar-Supported Monolayers. The model
membrane systems investigated here are prepared by transfer-
ring Langmuir monolayers from the water-air interface to
silanized glass supports. The short acyl chain of the silane is
covalently bound to the glass, and we assume that the structures
observed by fluorescence microscopy are based on the molecular
interactions present in the distal lipid leaflet. The strong contrast
for molecules partitioning between the observed two liquid
crystalline phases (CTB-labeled GM1, R ' 0.95; TR-DPPE,
R ' 0.05) indicates that this model system is able to preserve
interactions that cause and stabilize domain formation. The
lateral pressure at which lipid monolayers were transferred onto
planar supports ('32 dyneycm) was selected to mimic the
physiological density of phospholipid bilayers (41). Indeed, the
translational diffusion coefficients and fractional mobilities of
fluorescent lipid probes in the monolayers are similar to those in
planar-supported phospholipid bilayers (42–44) and the plasma
membrane of cells (45).
Raft Domains Critically Depend on the Cholesterol Content. The
reversible disruption and formation of domains upon changing
cholesterol levels in the lipid monolayers (Figs. 1 and 2) dem-
onstrate that the lipid preparations are in thermodynamic ex-
change with the bulk phase and presumably close to equilibrium
with respect to their phase composition. The observation that
treating the supported monolayers with MbCD did not signifi-
cantly change the intensities (610%) or fractional recovery (0.92
6 0.04) of incorporated fluorescent lipid probes (FL-DPPE or
TR-DPPE) indicates that cholesterol can be added or extracted
without impairing the integrity of the lipid leaflet, similar to lipid
monolayers at the water-air interface (34). The very effective
and prompt disruption of the model raft domains upon MbCD
treatment (Figs. 1b and 2a) lends strong credence to the notion
that certain signaling and sorting events in cells are based on
cholesterol-enriched membrane domains termed rafts.
Fig. 5. Effect of cross-linking on the distribution of fluorescent phospholipid analogs between the liquid-disordered and raft-like phases. Monolayers were
prepared from DOPCySMycholesterol containing 1 mol% GM1 and 0.5 mol% FL-DOPE or 0.5 mol% FL-DPPE, and transferred onto silanized glass coverslips at
32 dyneycm. Typical fluorescence micrographs are shown for monolayers containing (Upper) FL-DOPE and (Lower) FL-DPPE. The yellow images show the
distributions of the fluorescent lipids as monitored by measuring fluorescein fluorescence in the green channel. The red images illustrate the distributions of
complexes of fluorescent lipids and Alexa594-conjugated antifluorescein polyclonal antibodies as determined by measuring Alexa594 fluorescence in the red
channel. The green images show the corresponding distribution of GM1 as indicated by measuring the fluorescence in the green channel for monolayers after
treatment with antibodies and then FL-CTB. To achieve accurate representations of FL-CTB densities, the offsets in the green panels were determined as the
average intensities measured in the green channel before FL-CTB binding. The plots depict the relative partitioning, R, into the raft-like phase for fluorescent
lipid analogs before and after cross-linking with antibodies before FL-CTB incubation. T 5 24°C. (Bars are 5 mm.)
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GPI-Anchored Proteins Partition into Raft Domains. Significant
amounts of F-Thy-1, used as a representative GPI-anchored
protein, partition into the raft-like phase in supported lipid
monolayers (Figs. 3 and 4). The highest F-Thy-1 partition
coefficient was found for BBM preparations without GM1 (R
' 0.60); for Thy-1 partitioning into monolayers made from
synthetic lipid mixtures, R was lower (R ' 0.40). The extent to
which GPI-anchored proteins are recruited into rafts in cell
membranes and the conditions for which this lateral sorting
occurs are not yet clearly understood (20, 46, 47). GM1, which
does not significantly affect the partitioning of the lipid analog
TR-DPPE between the liquid-disordered and liquid-ordered
phases, reduces the abundance of F-Thy-1 in the raft phase when
added in small amounts (1 mol%, Fig. 4). The competition by
GM1 and F-Thy-1 for raft residency could be because both
molecules have large extracellular domains capable of ordering
the aqueous face of the raft domains even when these molecules
are present at relatively low densities. It is also possible that GM1
alters raft-like domain structure, reducing Thy-1 partitioning
into them. Indeed, a recent study has shown that increased levels
of GM1 displace GPI-anchored proteins from sphingolipid-
cholesterol microdomains in living cells (48).
Selective Partitioning of Cross-Linked Components into Raft Domains.
The fact that physical cross-linking results in movement from the
liquid-disordered to the liquid-ordered phase is quite striking
given that the initial event in signal transduction, for many
receptors, is cross-linking and that lipid rafts on cell membranes
are thought to function as preassembled signal transduction
complexes. A possible physical explanation for the result that
cross-linking FL-DPPE with antif luorescein antibodies results in
translocation to the raft-phase regions is that protein binding
orders the FL-DPPE acyl chains. This notion is consistent with
previous work showing that protein binding to lipids in phos-
pholipid monolayers and bilayers can decrease hydrocarbon
chain flexibility (49) and reduce lipid translation mobility (50,
51). An additional factor might be the increased ability of the
larger head groups with their bound antibody to shield choles-
terol from water (52). At this point it is important to note that
CTB forms stable pentamers (53), offering binding sites for five
GM1 lipids. Because we detect the distribution of CTB-GM1
complexes, the possibility that monomeric GM1 partitions dif-
ferently into the coexisting phases cannot be excluded. Our
results indicate that a delicate interplay of head-related and
tail-related interactions determine the tendency to partition into
the cholesterol-dependent liquid-ordered (‘‘raft’’) phases. Over-
all, it is striking how many tenets of the raft hypothesis can be
confirmed in model membranes.
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